Abstract: An apparatus, method, and computer program product for achieving interoperability between cryptographic key recovery enabled and unaware systems. The method includes the steps of encrypting data using a cryptography key to generate ciphertext; generating a key recovery block containing key recovery information for the ciphertext; determining whether a receiver for the ciphertext is key recovery unaware; and sending the key recovery block to a key recovery client when it is determined that the receiver is key recovery unaware. In a preferred embodiment, the ciphertext is sent to the receiver only after receiving confirmation from the key recovery client of the receipt of the key recovery block. Also in a preferred embodiment, the key recovery block is sent as part of an Internet Message Control Protocol (ICMP) message.

Abstract: The present invention provides a dental device that comprises a hemostatic agent and a method of making and using a dental device comprising a hemostatic agent.

Abstract: Coatings are formed by applying to article a copolymer of a water soluble base polymer having graft polymerized thereto an organic moiety that includes a group that reacts with water to form a silanol group, and then curing the copolymer to form a crosslinked hydrogel coating that is absorbent, lubricious and substantially non-water soluble. Coating compositions, coated articles the subject coatings are also described.

Abstract: The present invention provides a dental device that comprises a hemostatic agent and a method of making and using a dental device comprising a hemostatic agent.

Abstract: An apparatus, method, and computer program product for high-availability multi-agent cryptographic key recovery. The present invention defines a key recovery block that specifies allowable subsets of the total set of key recovery agents that can participate in a key recovery. For each subset, key recovery information is computed and stored after the subset is specified. This key recovery information is only useable by that subset because it is computed using that subset of public keys of the agents. When key recovery is initiated, a trusted processor (a key recovery coordinator) validates the contents of the key recovery block and it uses and is allowed to use any of the subsets of the agents to process the key recovery request. Since many subsets could be specified, the likelihood of key recovery failure is greatly diminished.

Abstract: A method of preparing multicomponent salts of a compound in aqueous solution includes the steps of first selecting at least a weak acid, then selecting at least a first weak base, mixing an equivalent mole amount of the weak acid with the weak base in water to form an aqueous solution, adding at least a second weak base, to the solution and, finally, mixing the aqueous solution to yield a multicomponent salt composition.

Abstract: Novel compositions containing at least one biologically active component derived from peat or similar composition, methods for their preparation and therapeutic uses for a variety of diseases, injuries, and conditions, including wound healing, pain, itch, inflammation, abnormal cell proliferation, or infections caused by fungal, bacterial, rickettsial or viral agents, psoriasis, allergic and other dermatitis, pruritis, eczema, actinic keratosis and similar conditions. In addition, the compositions can be used as diuretics, antiarrhythmics, and cardiac-stimulating agents, as well as for the treatment of mammalian diseases and disorders, including multiple drug resistance, cancers, asthma, rheumatoid arthritis, pain, wound healing, fungal disorders, and other inflammatory disorders. The compositions are derivable from peat or peat-related substances and may alternatively be synthetically produced.

Abstract: A method, system, and computer program are disclosed to transport an encrypted key across multiple, diverse systems which provides the relevant and necessary information to guarantee a successful decryption of the key. The method prepares an ASN.1 encoding file at the sender which contains the key. The receiver performs the method to decode the ASN.1 encoded file. In this manner, only the data and the contents of the portable key need to be sent to guarantee successful decryption at the receiver.

Abstract: A method is disclosed for communicating a key recovery block from a sender to a non-enabled receiver, without the danger of throwing the receiver into an indeterminant state, and without modifying the receiver. The method uses an unmodified communications protocol that has a standard method to receive and acknowledge arbitrary data. The sender sends a message using the standard method for arbitrary data, and includes in the message the key recovery block. The receiver responds with a standard acknowledgment message. The method thereby enables an entity coupled to the link, to monitor the key recovery block, even though the receiver is not enabled to process it.

Abstract: Compositions derived from Gymnema sylvestre leaf materials are disclosed. Methods for isolating such compositions are also disclosed. The compositions may be administered orally, intravenously, subcutaneously or transdermally and are useful for treating patients having diabetes, impaired glucose tolerance, and various conditions associated with or symptoms of diabetes. Additionally, the compositions reduce polydipsia, polyuria and polyphagia, regenerate the pancreatic islets of Langerhans, including beta cells, increase endogenous insulin, lipase and amylase levels, increase production of proinsulin and c-peptide, and lower blood lipids and triglycerides and free fatty acids.

Abstract: Modulation of substance P by compounds containing calcium sulfate is disclosed. Preferred calcium sulfate compounds include syngenite, gorgeyite and gypsum. Methods of this invention include the modulation of substance P, as well as methods for preventing or treating conditions associated with substance P, by administering to an animal an effective amount of a calcium sulfate compound. Conditions associated with substance P include headaches and migraine, neurogenic inflammation, emesis, nausea and vomiting, cough and bronchitis, obesity, allergy, asthma, hemorrhoids and anal fissures, ulcer, fever, infertility and periodontal disease.

Abstract: Apolipoprotein A1 is prepared in a T7 RNA polymerase/promoter bacterial expression system that optimizes yield and facilitates subsequent purification of the protein. Apolipoprotein A1 cDNA is cloned into an Escherichia coli plasmid containing a bacteriophage T7 RNA polymerase promoter such as a pT or pET plasmid; the recombinant plasmid is transferred to an E. coli strain containing inducible bacteriophage T7 RNA polymerase, e.g., a strain having the enzyme under lac control; T7 RNA polymerase is induced in the strain; and apolipoprotein A1 is isolated from the culture. Preferred embodiments tag the apolipoprotein with a sequence such as a stretch of histidines that facilitates purification subsequent to expression. An especially preferred embodiment employs a pET11d-6His plasmid and E.